| Dr Norman Senzaki, DDS | |
|
3410 Mccall Ave, Suite 110, Selma, CA 93662-2500 | |
| (559) 891-7538 | |
| (559) 891-1762 |
| Full Name | Dr Norman Senzaki |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 3410 Mccall Ave, Selma, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588711527 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 28237 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Norman Senzaki, DDS 3410 Mccall Ave, Suite 110, Selma, CA 93662-2500 Ph: (559) 891-7538 | Dr Norman Senzaki, DDS 3410 Mccall Ave, Suite 110, Selma, CA 93662-2500 Ph: (559) 891-7538 |
News Archive
The likelihood of people dying because their medication has a side effect that affects the electrical activity of the heart is being reduced - thanks to a better understanding of why this happens and the development of tests to predict it.
After a rigorous selection process, one of the nation's largest and most prestigious cancer centers, Roswell Park Cancer Institute, has selected McKesson to manage its medical billing processes. With McKesson's Revenue Management Solutions group taking over patient billing, accounts receivable management, and reporting, the New York-based education and research institute gains a partner that understands the complexities of its business.
A recent study reported by Haigang Chang and co-workers from the First Affiliated Hospital of Xinxiang Medical University in China verified the effects of transient axonal glycoprotein-1 (TAG-1) on cell viability and p53, epidermal growth factor receptor (EGFR), and amyloid precursor protein (APP) intracellular C-terminal domain (AICD) expression in U251 glioma cells.
Acriflavine is traditionally employed as a topical antiseptic, though has more recently been implicated as an antiviral agent at low doses, potentially by stimulating the production of interferon. In a new study recently uploaded to the bioRxiv* preprint server, the application of the drug to SARS-CoV-2 infection is investigated, demonstrating a broad activity towards a range of other betacoronaviruses.
Results from a phase III trial have shown that tecemotide is no more effective than placebo as maintenance therapy in patients with non-small-cell lung cancer.
› Verified 6 days ago
Deborah Finegold, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1164 Rose Ave, Selma, CA 93662 Phone: 559-896-3145 Fax: 559-896-7042 | |
Katelyn Nicole Van Leir-morales, DMD Dentist Medicare: Medicare Enrolled Practice Location: 2705 Highland Ave, Selma, CA 93662 Phone: 800-492-4227 | |
Mr. Donald Henry Jacobsen, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1221 Rose Ave, Selma, CA 93662 Phone: 559-896-1244 Fax: 559-896-1244 | |
Dr. Mark Sheng Chich Kuo, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1219 Rose Avenue, Selma, CA 93662 Phone: 559-896-3145 Fax: 559-896-7042 | |
Dr. Galen Glenn Rusk, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3410 Mccall Ave, Suite 104, Selma, CA 93662 Phone: 559-896-2445 Fax: 559-896-3259 | |
Dr. David Melvin Engstrom, DMD Dentist Medicare: Medicare Enrolled Practice Location: 1122 Rose Ave, Suite 1, Selma, CA 93662 Phone: 559-896-0323 Fax: 559-896-9251 | |
Dr. Navjot Sihota, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 14409 South Dewolf Ave, Selma, CA 93662 Phone: 559-296-2012 Fax: 559-896-5862 |